Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that it has filed a lawsuit...
Madison-based Exact Sciences says St. Louis-based Geneoscopy's new ColoSense test violates a patent on collecting and processing stool samples.
Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S.
Madison-based Exact Sciences says St. Louis-based Geneoscopy's new ColoSense test violates a patent on collecting and processing stool samples.
Madison-based Exact Sciences says St. Louis-based Geneoscopy's new ColoSense test violates a patent on collecting and processing stool samples.